Roger Bird is President & VP at ABBOTT LABORATORIES (ABT). They have made 13 open-market trades across 1 company since 2015, most recently 2021-04-27.
CIK 0001635313
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 13 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ABT | 51,083 | $5.9M |
Shares reported on the most recent Form 4, priced at the 2021-04-29 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ABT | SELL | 2021-04-27 | 2021-04-29 | $122.00 | $1.2M | -1.8% | -12.2% | +0.0% |
| ABT | SELL | 2021-03-01 | 2021-03-02 | $120.61 | $268K | -4.1% | -2.3% | -13.1% |
| ABT | SELL | 2020-09-01 | 2020-09-03 | $108.73 | $1.4M | +0.2% | +2.9% | +2.6% |
| ABT | SELL | 2020-03-02 | 2020-03-03 | $77.89 | $104K | +1.2% | -1.5% | +15.3% |
| ABT | SELL | 2019-03-13 | 2019-03-14 | $79.06 | $726K | -0.0% | -1.9% | +3.7% |
| ABT | SELL | 2019-03-01 | 2019-03-04 | $78.00 | $87K | +0.5% | +1.2% | -3.6% |
| ABT | SELL | 2018-03-09 | 2018-03-13 | $62.75 | $1.0M | -6.2% | -7.2% | -0.5% |
| ABT | SELL | 2018-03-01 | 2018-03-02 | $58.80 | $97K | +6.7% | -1.2% | +4.4% |
| ABT | SELL | 2017-04-27 | 2017-04-28 | $43.82 | $245K | +2.2% | +3.4% | +15.1% |
| ABT | SELL | 2017-02-28 | 2017-03-02 | $45.02 | $144K | -1.4% | -2.1% | +0.5% |
| ABT | SELL | 2017-02-22 | 2017-02-22 | $45.02 | $515K | +0.2% | -0.6% | -3.0% |
| ABT | SELL | 2017-02-21 | 2017-02-22 | $45.02 | $616K | +0.2% | -0.6% | -3.0% |
| ABT | SELL | 2015-04-27 | 2015-04-29 | $47.56 | $1.4M | -8.3% | -2.3% | -2.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.